Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
From Neoleukin Therapeutics, Inc.
Via GlobeNewswire
Tickers NLTX
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
From Neoleukin Therapeutics, Inc.
Via GlobeNewswire
Tickers NLTX
Neurogene and Neoleukin Announce Definitive Merger Agreement
From Neoleukin Therapeutics, Inc.
Via GlobeNewswire
Tickers NLTX
Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition
From Neoleukin Therapeutics, Inc.
Via GlobeNewswire
Tickers NLTX
Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
From Neoleukin Therapeutics, Inc.
Via GlobeNewswire
Tickers NLTX
Neoleukin Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Update
From Neoleukin Therapeutics, Inc.
Via GlobeNewswire
Tickers NLTX
Neoleukin Therapeutics Announces Oral Presentation at 64th American Society of Hematology (ASH) Annual Meeting
From Neoleukin Therapeutics, Inc.
Via GlobeNewswire
Tickers NLTX
Neoleukin Therapeutics to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 9, 2022
From Neoleukin Therapeutics, Inc.
Via GlobeNewswire
Tickers NLTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.